Clinical experience with iomeprol in myelography and myelo-CT: Clinical pharmacology and double-blind comparisons with iopamidol, iohexol, and iotrolan

Investigative Radiology

Volumn 36, Issue 1, 2001, Pages 22-32

  Katayama, Hitoshi ^c,d   Heneine, Nada ^a   Van Gessel, Roland ^b   Taroni, Paola ^a   Spinazzi, Alberto ^a  

^a Bracco SpA   (Italy)

^b ALTANA PHARMA AG   (Germany)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d JUNTENDO UNIVERSITY   (Japan)

Author keywords

Clinical pharmacology; Comparative clinical trials; Iomeprol; Myelo CT; Myelography

Indexed keywords

CONTRAST MEDIUM; IOHEXOL; IOMEPROL; IOPAMIDOL; IOTROLAN;

AREA UNDER THE CURVE; ARTICLE; CEREBROSPINAL FLUID; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GLOMERULUS FILTRATION; HUMAN; MAJOR CLINICAL STUDY; MYELOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBARACHNOID SPACE;

EID: 0035152338     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200101000-00004     Document Type: Article

References (28)

1. Neuroradiology of the spine
2. Myelographic contrast media
3. The spine
4. The chemistry of iomeprol and physicochemical properties of its aqueous solutions and pharmaceutical formulations
5. Status of contrast media research in MRI, ultrasound and x-ray
6. Toxicological safety assessment of iomeprol, a new x-ray contrast agent
7. Preclinical safety assessment of iomeprol for injection as contrast medium for myelography
8. Clinical pharmacology of iomeprol
9. High-performance liquid chromatography of iomeprol in plasma and urine
10. Pharmacokinetics and excretion of iohexol after lumbar myelography in man
11. Absorption of iohexol from cerebrospinal fluid to blood
12. Plasma level and renal excretion of iotrolan after lumbar injection in patients
13. An overview of the clinical pharmacokinetics of x-ray contrast media
14. Pharmacokinetics of iopamidol after intrathecal administration in humans
15. Myelography with a dimeric (iodixanol) and a monomeric (iohexol) contrast medium: A clinical multicentre comparative study
16. Postmyelography headache: A review
17. The contribution of needle size and other factors to headache following myelography
18. Side effects after diagnostic lumbar puncture and lumbar iohexol myelography
19. Outpatient myelography with fine-needle technique: An appraisal
20. Iohexol compared to metrizamide in cervical and thoracic myelography
21. Iopamidol for myelography: Practical implications
22. Adverse side effects of metrizamide in myelography
23. Subclinical organic psychosyndromes on intrathecal injection of metrizamide for lumber myelography
24. Transient encephalitis and asterixis following metrizamide myelography
25. Neuropsychologic reactions and other side effects after metrizamide myelography
26. Overview of U.S. clinical experience of intrathecal application of iopamidol
27. Theory and practice: How much contrast for myelography?